Cargando…

The Impact of Non-Ophthalmic Factors on Intravitreal Injections During the COVID-19 Lockdown

PURPOSE: Early on in the COVID-19 pandemic, it was difficult to know what factors would affect patient and physician decision-making regarding ophthalmic care utilization. The purpose of this study is to investigate the effect of non-ophthalmic factors on patient decision-making to receive intravitr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashrafzadeh, Sahar, Gundlach, Bradley S, Tsui, Irena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409597/
https://www.ncbi.nlm.nih.gov/pubmed/34483654
http://dx.doi.org/10.2147/OPTH.S314840
_version_ 1783747011862855680
author Ashrafzadeh, Sahar
Gundlach, Bradley S
Tsui, Irena
author_facet Ashrafzadeh, Sahar
Gundlach, Bradley S
Tsui, Irena
author_sort Ashrafzadeh, Sahar
collection PubMed
description PURPOSE: Early on in the COVID-19 pandemic, it was difficult to know what factors would affect patient and physician decision-making regarding ophthalmic care utilization. The purpose of this study is to investigate the effect of non-ophthalmic factors on patient decision-making to receive intravitreal injections during the COVID-19 lockdown. PATIENTS AND METHODS: Data on patients who had intravitreal injection appointments at a tertiary care Veterans Health Administration clinic during a seven-week period (March 19, 2020–May 8, 2020) of the COVID-19 outbreak in Los Angeles County were collected and compared to patients who had intravitreal injection appointments during the same time period in 2019. Demographic characteristics, injection diagnoses, visual acuities, body mass indices, co-morbidities, and psychiatric conditions of patients and clinic volumes were tabulated and compared between the two time periods. RESULTS: There were 86 patients in the injection clinic in 2020 compared to 176 patients in 2019. The mean age and gender of patients in the injection clinic did not differ between 2019 and 2020. Compared to 2019, the number of patients who identified as Hispanic or Latino remained nearly the same, but the number of patients who identified as White, Black, or Asian or Pacific Islander decreased by nearly half. In 2020, a greater proportion of patients came to the injection clinic for neovascular age-related macular degeneration (56.5% vs 39.3%, p=0.017), but a decreased proportion of patients diagnosed with a heart condition (OR 0.57, 95% CI 0.33, 0.96), chronic obstructive pulmonary disease (OR 0.43, 95% CI 0.21, 0.91), or asthma (OR 0.09, 95% CI 0.01, 0.70) came to the injection clinic. CONCLUSION: The COVID-19 pandemic was associated with behavioral changes in eyecare utilization influenced by race and systemic co-morbidities. These data can be used to design and implement strategies to address disparities in essential ophthalmic care among vulnerable populations.
format Online
Article
Text
id pubmed-8409597
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84095972021-09-02 The Impact of Non-Ophthalmic Factors on Intravitreal Injections During the COVID-19 Lockdown Ashrafzadeh, Sahar Gundlach, Bradley S Tsui, Irena Clin Ophthalmol Original Research PURPOSE: Early on in the COVID-19 pandemic, it was difficult to know what factors would affect patient and physician decision-making regarding ophthalmic care utilization. The purpose of this study is to investigate the effect of non-ophthalmic factors on patient decision-making to receive intravitreal injections during the COVID-19 lockdown. PATIENTS AND METHODS: Data on patients who had intravitreal injection appointments at a tertiary care Veterans Health Administration clinic during a seven-week period (March 19, 2020–May 8, 2020) of the COVID-19 outbreak in Los Angeles County were collected and compared to patients who had intravitreal injection appointments during the same time period in 2019. Demographic characteristics, injection diagnoses, visual acuities, body mass indices, co-morbidities, and psychiatric conditions of patients and clinic volumes were tabulated and compared between the two time periods. RESULTS: There were 86 patients in the injection clinic in 2020 compared to 176 patients in 2019. The mean age and gender of patients in the injection clinic did not differ between 2019 and 2020. Compared to 2019, the number of patients who identified as Hispanic or Latino remained nearly the same, but the number of patients who identified as White, Black, or Asian or Pacific Islander decreased by nearly half. In 2020, a greater proportion of patients came to the injection clinic for neovascular age-related macular degeneration (56.5% vs 39.3%, p=0.017), but a decreased proportion of patients diagnosed with a heart condition (OR 0.57, 95% CI 0.33, 0.96), chronic obstructive pulmonary disease (OR 0.43, 95% CI 0.21, 0.91), or asthma (OR 0.09, 95% CI 0.01, 0.70) came to the injection clinic. CONCLUSION: The COVID-19 pandemic was associated with behavioral changes in eyecare utilization influenced by race and systemic co-morbidities. These data can be used to design and implement strategies to address disparities in essential ophthalmic care among vulnerable populations. Dove 2021-08-28 /pmc/articles/PMC8409597/ /pubmed/34483654 http://dx.doi.org/10.2147/OPTH.S314840 Text en © 2021 Ashrafzadeh et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Ashrafzadeh, Sahar
Gundlach, Bradley S
Tsui, Irena
The Impact of Non-Ophthalmic Factors on Intravitreal Injections During the COVID-19 Lockdown
title The Impact of Non-Ophthalmic Factors on Intravitreal Injections During the COVID-19 Lockdown
title_full The Impact of Non-Ophthalmic Factors on Intravitreal Injections During the COVID-19 Lockdown
title_fullStr The Impact of Non-Ophthalmic Factors on Intravitreal Injections During the COVID-19 Lockdown
title_full_unstemmed The Impact of Non-Ophthalmic Factors on Intravitreal Injections During the COVID-19 Lockdown
title_short The Impact of Non-Ophthalmic Factors on Intravitreal Injections During the COVID-19 Lockdown
title_sort impact of non-ophthalmic factors on intravitreal injections during the covid-19 lockdown
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409597/
https://www.ncbi.nlm.nih.gov/pubmed/34483654
http://dx.doi.org/10.2147/OPTH.S314840
work_keys_str_mv AT ashrafzadehsahar theimpactofnonophthalmicfactorsonintravitrealinjectionsduringthecovid19lockdown
AT gundlachbradleys theimpactofnonophthalmicfactorsonintravitrealinjectionsduringthecovid19lockdown
AT tsuiirena theimpactofnonophthalmicfactorsonintravitrealinjectionsduringthecovid19lockdown
AT ashrafzadehsahar impactofnonophthalmicfactorsonintravitrealinjectionsduringthecovid19lockdown
AT gundlachbradleys impactofnonophthalmicfactorsonintravitrealinjectionsduringthecovid19lockdown
AT tsuiirena impactofnonophthalmicfactorsonintravitrealinjectionsduringthecovid19lockdown